Chevy Chase Trust Holdings LLC cut its position in shares of The Allstate Co. (NYSE:ALL – Free Report) by 1.8% during the third quarter, HoldingsChannel.com reports. The firm owned 141,574 shares of the insurance provider’s stock after selling 2,537 shares during the period. Chevy Chase Trust Holdings LLC’s holdings in Allstate were worth $26,850,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also modified their holdings of ALL. Pathway Financial Advisers LLC lifted its holdings in shares of Allstate by 18,472.5% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after acquiring an additional 1,047,019 shares during the period. Allspring Global Investments Holdings LLC raised its position in Allstate by 18.7% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock worth $569,114,000 after purchasing an additional 472,040 shares in the last quarter. AQR Capital Management LLC lifted its stake in Allstate by 181.6% during the second quarter. AQR Capital Management LLC now owns 719,997 shares of the insurance provider’s stock worth $114,955,000 after purchasing an additional 464,337 shares during the period. TimesSquare Capital Management LLC acquired a new stake in Allstate during the third quarter valued at approximately $77,819,000. Finally, Acadian Asset Management LLC grew its stake in shares of Allstate by 3,839.0% in the 2nd quarter. Acadian Asset Management LLC now owns 416,117 shares of the insurance provider’s stock valued at $66,417,000 after purchasing an additional 405,553 shares during the period. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Allstate Stock Down 1.4 %
NYSE ALL opened at $204.39 on Tuesday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The Allstate Co. has a 52 week low of $134.17 and a 52 week high of $209.88. The stock has a market capitalization of $54.12 billion, a P/E ratio of 13.24, a price-to-earnings-growth ratio of 1.82 and a beta of 0.48. The stock has a fifty day moving average of $193.02 and a 200-day moving average of $179.19.
Allstate Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be paid a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date of this dividend is Friday, November 29th. Allstate’s dividend payout ratio (DPR) is 23.83%.
Insider Activity at Allstate
In other Allstate news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the sale, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. The trade was a 57.06 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.80% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
Several analysts recently commented on ALL shares. Bank of America boosted their price target on Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a research note on Friday, October 18th. The Goldman Sachs Group boosted their target price on shares of Allstate from $209.00 to $230.00 and gave the company a “buy” rating in a research note on Friday, November 15th. Roth Mkm reiterated a “buy” rating and set a $200.00 target price on shares of Allstate in a research report on Wednesday, August 14th. Jefferies Financial Group boosted their price target on shares of Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Finally, Barclays raised their price objective on shares of Allstate from $175.00 to $187.00 and gave the stock an “underweight” rating in a report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Allstate presently has an average rating of “Moderate Buy” and an average price target of $217.19.
View Our Latest Research Report on ALL
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles
- Five stocks we like better than Allstate
- The How and Why of Investing in Gold Stocks
- How to Master Trading Discipline: Overcome Emotional Challenges
- Are Penny Stocks a Good Fit for Your Portfolio?
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- What is the Australian Securities Exchange (ASX)
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.